用户名:
密 码:
注册
|
忘记密码?
首 页
药品信息
药品检索
全部药品
适应症分类
热门药品
专利信息
专利检索
专利权人导航
专利权人分组导航
分类查询
IPC导航
热门检索
专利分析
概况
申请趋势分析
申请人分析
发明人分析
IPC分析
项目文档
项目
个人项目
文档
个人文档
企业文档
公共文档
标签
互动
特色功能
广州科技订制咨询
特色资讯
医药新闻
帮助中心
关于本软件
药品
文档
专利
新闻
所有专利
选择导航
专利权人导航
专利权人分组导航
分类导航
专利权人导航
Pfizer Inc.(1170)
专利信息
Translation Company
查询条件
展开筛选条件
[专利权人] 包含 'Pfizer Inc.'
清空条件
查询
分析
排序
公开日
公开号
申请日
申请号
中文标题
英文标题
降序
升序
翻到页码
标题
标题2
专利权人
发明人
附图
摘要
摘要2
优先权号
IPC
专利类型
首页
上页
1
2
3
4
5
6
7
8
下页
尾页
共
1170
条记录, 当前第3/117页。
公开号
公开日
申请号
申请日
1.
US7649003B2
2010/1/19
US11/928513
2007/10/30
专利标题
:Substituted triazole derivatives as oxytocin antagonists
专利权人
:
Pfizer Inc.
;
The present invention relates to a class of substituted 124-triazoles of formula (1) with activity as oxytocin antagonists uses thereof processes for the preparation thereof and compositions containing said inhibitors. These inhibitors have utility in a variety of therapeutic areas including sexual dysfunction particularly premature ejaculation (P.E.).
2.
US20100003331A1
2010/1/7
专利标题
:Sustained release dosage forms of ziprasidone
专利权人
:
Pfizer Inc.
;
A sustained release solid oral dosage form for treatment of a psychotic disorder for example schizophrenia in a mammal is provided which oral dosage form comprises ziprasidone in an amount effective in treating said psychotic disorder and a pharmaceutically acceptable carrier.
3.
TW200950783A
2009/12/16
专利标题
:Methods, dosage forms, and kits for administering ziprasidone without food
专利权人
:
Pfizer Inc.
;
The present invention provides methods dosage forms and kits for treating with an effective amount of ziprasidone a CNS disorder in a human when the human is in a fasted state. In one embodiment the invention relates to a method for treating a CNS disorder in a human which method comprises administering to the human in a fasted state a solid oral dosage form comprising an amount of ziprasidone effective to treat said CNS disorder wherein the area under the serum concentration versus time curve (...
4.
CA2475712C
2009/11/24
CA20032475712
2003/2/3
专利标题
:Nicotinamide derivatives useful as pde4 inhibitors
专利权人
:
Pfizer Inc.
;
The invention relates to nicotinamide derivatives of formula (1) and to processes for the preparation of intermediates used in the preparation of compositions containing and the uses of such derivatives. The nicotinamide derivatives according to the present invention are phosphodiesterase-4 inhibitors and are useful in numerous diseases disorders and ( conditions in particular inflammatory allergic respiratory diseases disorders and conditions as well as wounds.
5.
WO2009109844A1
2009/9/11
专利标题
:Methods, dosage forms, and kits for administering ziprasidone without food
专利权人
:
Pfizer Inc.
;
The present invention provides methods dosage forms and kits for treating with an effective amount of ziprasidone a CNS disorder in a human when the human is in a fasted state. In one embodiment the invention relates to a method for treating a CNS disorder in a human which method comprises administering to the human in a fasted state a solid oral dosage form comprising an amount of ziprasidone effective to treat said CNS disorder wherein the area under the serum concentration versus time curve (...
6.
CA2719115A1
2009/9/11
专利标题
:Methods, dosage forms, and kits for administering ziprasidone without food
专利权人
:
Pfizer Inc.
;
The present invention provides methods dosage forms and kits for treating with an effective amount of ziprasidone a CNS disorder in a human when the human is in a fasted state. In one embodiment the invention relates to a method for treating a CNS disorder in a human which method comprises administering to the human in a fasted state a solid oral dosage form comprising an amount of ziprasidone effective to treat said CNS disorder wherein the area under the serum concentration versus time curve (...
7.
WO2009081246A3
2009/9/3
专利标题
:Bicyclic diamines as nicotinic receptor agonists
专利权人
:
Pfizer Inc.
;
Compounds; pharmaceutically acceptable salts thereof; and stereoisomers of the compound of Formula I and pharmaceutically acceptable salts thereof; are disclosed wherein the compounds have the structure of Formula (I) as defined in the specification. Corresponding pharmaceutical compositions and methods of treatment are also disclosed.
8.
US20090221839A1
2009/9/3
US12/065555
2008/9/3
专利标题
:Preparation of an atorvastatin intermediate
专利权人
:
Pfizer Inc.
;
Atorvastatin lactone is prepared by hydrogenating tert-butyl isopropylidene nitrile to tert-butyl isopropylidene amine and condensing the amine with the diketone of atorvastatin to form acetonide ester. The diol protecting acetonide ester is deprotected to form a diol ester by dissolving the acetonide ester in methanol and treating with an acid. The diol ester is saponified to form a sodium salt. Methanol is removed from the reaction mixture by distillation. The sodium salt is reacidified to the...
9.
US20090221852A1
2009/9/3
专利标题
:Preparation of an atorvastatin intermediate
专利权人
:
Pfizer Inc.
;
The diketone of atorvastatin is prepared by first washing a reaction vessel with a non-ketonic solvent especially tetrahydrofuran to remove water. 4-fluorobenzaldehyde is then reacted with benzylidine isobutyryl acetanilide in the reaction vessel to form 4-fluoro-alpha-(2-methyl-1-oxopropyl)-gamma-oxo-Nbeta-diphenylbenzene-butanainide
10.
WO2009081246A2
2009/7/2
专利标题
:Bicyclic diamines as nicotinic receptor agonists
专利权人
:
Pfizer Inc.
;
Compounds; pharmaceutically acceptable salts thereof; and stereoisomers of the compound of Formula I and pharmaceutically acceptable salts thereof; are disclosed wherein the compounds have the structure of Formula (I) as defined in the specification. Corresponding pharmaceutical compositions and methods of treatment are also disclosed.
首页
上页
1
2
3
4
5
6
7
8
下页
尾页
共
1170
条记录, 当前第3/117页。
当前查询条件: [专利权人] 包含 'Pfizer Inc.'
查询范围
在当前结果中查询
!
专利类型
发明
实用新型
外观设计
!
公开号
CN1234
!
申请号
CN1234
!
专利标题
扩展
PHARMA
!
专利权人
扩展
pfizer
发明人
!
申请日
yyyymmdd
!
公开日
yyyymmdd
优先权号
!
摘要
扩展
PHARMA
IPC
A01B
下载范围
下载第
到
条记录。
下载内容
题录信息
专利全文